Molecule Details
| InChIKey | OKFFBZNIDUDHDR-UHFFFAOYSA-N |
|---|---|
| Compound Name | 4-((4-((4-(3-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)ureido)naphthalen-1-yl)oxy)pyrimidin-2-yl)amino)-3-methoxy-N-(2-morpholinoethyl)benzamide |
| Canonical SMILES | COc1cc(C(=O)NCCN2CCOCC2)ccc1Nc1nccc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)n1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.25 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile